0 Comments
0 Shares
48 Views
0 Reviews
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
Breakthrough Treatments Reshaping the Glioblastoma Multiforme MarketGlioblastoma multiforme (GBM) is the most aggressive form of brain cancer, with a poor prognosis and limited treatment options. The current glioblastoma multiforme survival rate remains dismal, with the majority of patients surviving only 12 to 18 months post-diagnosis. However, promising advancements in treatment, including the IMVAX clinical trial, are paving the way for...0 Comments 0 Shares 950 Views 0 Reviews
-
Rising Glioblastoma Cases and Unmet Needs Pushing Market ExpansionGlioblastoma Multiforme (GBM) is the most aggressive and lethal form of brain cancer, with a poor prognosis and limited treatment options. Despite advancements in cancer research, the survival rate for GBM patients remains low, highlighting the urgent need for more effective therapies. The current standard of care includes surgery, radiation, and chemotherapy, but these treatments...0 Comments 0 Shares 970 Views 0 Reviews